Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Go back to Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval| Agilent Technologies Inc (NYSE: A) | Delayed: 126.49 -0.57 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $127.06 | 52 Week High | $48.63 | |||
| Open | $126.69 | 52 Week Low | $34.15 | |||
| Day High | $127.90 | P/E | 58.56 | |||
| Day Low | $125.57 | EPS | $2.16 | |||
| Volume | 2,187,076 | |||||
| (NASDAQ: AUTL) | Delayed: 1.49 -0.02 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.51 | 52 Week High | $ | |||
| Open | $1.52 | 52 Week Low | $ | |||
| Day High | $1.57 | P/E | N/A | |||
| Day Low | $1.49 | EPS | $ | |||
| Volume | 789,449 | |||||
